Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Serum Institute may have to make some changes in the composition of its Covid-19 vaccine. This is to provide protection against the virulent South African strain — B.1.351 variant — of the virus, News 18 reported.
The World Health Organisation’s (WHO) Strategic Advisory Group of Experts on Immunisation (SAGE) reported limited effectiveness of the vaccine developed by the University of Oxford and British pharma major AstraZeneca that goes by the name of Covishield in India, against the South African strain.
Also read: Slow mutation of the Covid pandemic
South Africa has also halted AstraZeneca’s Covid-19 vaccine inoculation, citing limited protection.
According to a report in the Mint, on Monday and Tuesday, SAGE examined the vaccine’s effectiveness on the new SARS CoV-2 variants before making recommendations.
The development comes after WHO’s COVAX (Covid-19 Vaccines Global Access) signed advance purchase agreements with AstraZeneca and SII. It also announced a distribution of around 350 million doses in the next six months. However, Covishield is yet to receive a green signal for global use by COVAX.
Also read: South Africa puts hold on AstraZeneca’s Covid-19 vaccine over its low efficacy
According to media reports, so far India has reported only one mutation of the virus currently in circulation, i.e. the UK variant. The government has claimed that Bharat Biotech’s Covaxin works against the mutant strain.
Furthermore, the government maintained that the surveillance for mutations in the virus will be speeded up as vaccine efficacy concerns have been raised by South Africa.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
With initial public offerings galore, we give you a cheat sheet to score some good grades
Biggest risk in selling funds in a rising scenario is exiting early and missing out on further gains
Go for a standard vector-borne diseases policy if you don’t have a regular health plan
No credit risk is an attraction, but note the nuances
After facing severe droughts for several years, farmers in western Maharashtra have turned the corner through ...
A toast to a traditional drip irrigation system still going strong in the Northeast
Raza Mir’s ‘Murder at the Mushaira’ works well as a historical novel that captures the sunset years of the ...
If you see garbage lying on the streets, remove it, says a dedicated plogger on a clean-up drive
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...